Skip to content
HowShorted

Candel Therapeutics, Inc. short interest in 2022

In 2022, Candel Therapeutics, Inc.'s disclosed short interest ran from 0.16% of shares outstanding on 14 Jan 2022 to 0.11% on 30 Dec 2022, a change of -0.05 percentage points. The year's high was 0.32% on 31 May 2022 and its low 0.11% on 30 Dec 2022, averaging 0.19% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.18 days on 29 Jul 2022. Full history: Candel Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Candel Therapeutics, Inc. in 2022

2022 in figures

Start of year
0.16% (14 Jan 2022)
End of year
0.11% (30 Dec 2022)
Change
-0.05 pp
High
0.32% (31 May 2022)
Low
0.11% (30 Dec 2022)
Average
0.19%
Highest days to cover
17.18 (29 Jul 2022)
SEC filings marked
8

Every report in 2022

Candel Therapeutics, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20220.16%1.70
31 Jan 20220.18%1.00
15 Feb 20220.17%2.37
28 Feb 20220.21%2.74
15 Mar 20220.18%1.62
31 Mar 20220.21%1.2310-K filed, results (8-K)
14 Apr 20220.25%1.75
29 Apr 20220.18%1.00
13 May 20220.21%2.6910-Q filed, results (8-K)
31 May 20220.32%3.21
15 Jun 20220.22%4.95
30 Jun 20220.24%8.11
15 Jul 20220.22%12.27
29 Jul 20220.20%17.18
15 Aug 20220.18%2.6510-Q filed, results (8-K)
31 Aug 20220.17%1.67
15 Sep 20220.18%1.99
30 Sep 20220.20%2.81
14 Oct 20220.17%4.73
31 Oct 20220.16%1.00
15 Nov 20220.15%1.0910-Q filed, results (8-K)
30 Nov 20220.13%3.86
15 Dec 20220.18%1.00
30 Dec 20220.11%1.00

See also: Candel Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.